ロード中...
Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions
Biomedical preventions for HIV, such as vaccines, microbicides or pre-exposure prophylaxis (PrEP) with antiretroviral drugs, can each only partially prevent HIV-1 infection in most human trials. Oral PrEP is now FDA approved for HIV-prevention in high risk groups, but partial adherence reduces effic...
保存先:
| 出版年: | Hum Vaccin Immunother |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215580/ https://ncbi.nlm.nih.gov/pubmed/27679928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1231258 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|